{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:00:35Z","timestamp":1791234035726,"version":"4.1.0"},"reference-count":123,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Multiple myeloma (MM) is a clonal plasma cell malignancy that remains largely incurable despite major therapeutic advances. T\u2010cell\u2010redirecting bispecific antibodies (BsAbs) and chimeric antigen receptor T (CAR\u2010T) cells have recently emerged as highly effective therapies in relapsed\/refractory MM, inducing deep responses even in heavily pretreated patients. However, disease relapse, limited durability of response, and treatment\u2010related toxicities remain frequent, underscoring the need to better understand mechanisms of resistance. Accumulating evidence indicates that the tumor microenvironment (TME) plays a central role in shaping BsAb efficacy in MM. Immunosuppressive cellular components, including regulatory T\u2010cells, myeloid\u2010derived suppressor cells, and dysfunctional antigen\u2010presenting cells, as well as inhibitory cytokines, hypoxia, and metabolic constraints within the TME, profoundly impair T\u2010cell activation, expansion, and persistence following BsAb engagement. In addition, chronic CD3 stimulation within the TME may promote T\u2010cell exhaustion, contributing to suboptimal responses and disease progression. This review focuses on the dynamic interplay between BsAbs and the MM TME, highlighting how microenvironment\u2010driven immune suppression, antigen escape, and impaired T\u2010cell fitness influence clinical outcomes. We further discuss emerging strategies designed to overcome these barriers, including rational combination approaches, immunomodulatory agents, and next\u2010generation trispecific antibodies that enhance co\u2010stimulation or dual\u2010antigen targeting. Understanding and therapeutically modulating the TME represents a critical step toward improving the depth, durability, and safety of BsAb\u2010based therapies in MM.<\/jats:p>","DOI":"10.1111\/ejh.70168","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:15:09Z","timestamp":1773965709000},"page":"55-73","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Microenvironment in Bispecific Antibodies Treatment in Multiple Myeloma"],"prefix":"10.1111","volume":"117","author":[{"given":"Serena","family":"Barachini","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine University of Pisa  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Cassano Cassano","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences University of Foggia  Foggia Italy"},{"name":"University of Washington, Fred Hutchinson Cancer Center  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ronca","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology and Critical Area University of Pisa  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Petrini","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Surgery and Medicine University of Pisa  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Galimberti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Hematology University of Pisa  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Buda","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Hematology University of Pisa  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14213"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010022\u201001531\u20102"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213614"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303379"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203478"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010023\u201002528\u20109"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204591"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020613"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020217"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.669381"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2016.00114"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015\u2010024\u201010749\u20109"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27285"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.29924"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063359"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590\u2010021\u201000931\u20103"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1345678"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007415"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045\u2010024\u201001567\u20102"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102016\u201004\u2010633040"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010024\u201045678\u2010x"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.012"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10143150"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.50"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2016.02.013"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133213"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951\u2010024\u201002512\u20106"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3427"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.12.006"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1000106"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.703878"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000506174"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202702"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1155621"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010019\u20100543\u20104"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.CCR\u201014\u20101088"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008\u20105472.CAN\u201019\u20102714"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010024\u201002150\u2010x"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.008"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008935"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230567"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00501"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.123456"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262\u2010016\u20101849\u2010y"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.04.007"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102540"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030577"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14660"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010055"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.604331"},{"issue":"10","key":"e_1_2_13_54_1","first-page":"2251","article-title":"A Phase I Study of \u03b3\u2010Secretase Inhibitor Plus BCMAtargeted\u2010 CART Cells in Relapsed\/Refractory\u2010 Multiple Myeloma","volume":"4","author":"Lyu M. A.","year":"2020","journal-title":"Blood Advances"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010023\u201002491\u20105"},{"key":"e_1_2_13_56_1","unstructured":"N.Martin E.Thompson J.Dell'Aringa et\u00a0al. \u201cCorrelation of Tumor BCMA Expression With Response and Acquired Resistance to Idecabtagene Vicleucel in the KarMMa Study \u201dEHA25 Virtual Congress (2020) (Nota: Abstract congressuale no PMID disponibile)."},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.266841"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102017\u201006\u2010741058"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132337"},{"key":"e_1_2_13_60_1","doi-asserted-by":"crossref","unstructured":"J.Watkins\u2010Yoon W.Guzman A.Somanchi et\u00a0al. \u201cCTX\u20108573 an Innate\u2010Cell Engager Targeting BCMA Is a Highly Potent Multispecific Antibody for the Treatment of Multiple Myeloma \u201dAsh 2019 (Nota: Abstract Congressuale no PMID Disponibile).","DOI":"10.1182\/blood-2019-128749"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045\u2010015\u20100188\u20103"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428\u2010019\u201002725\u20103"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2422"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.15.77"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040591"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.11.1677"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.11.1747"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.CCR\u201015\u20102224"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8333"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.5641.5641"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000050"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2189"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8011"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-0007"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010023\u201002589\u2010w"},{"key":"e_1_2_13_76_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.01008"},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01504"},{"key":"e_1_2_13_78_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7531"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-159009"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535\u20107163.MCT\u201018\u20101216"},{"issue":"6","key":"e_1_2_13_81_1","first-page":"e410","article-title":"Talquetamab in Relapsed or Refractory Multiple Myeloma: Updated Results From the MonumenTAL\u20101 Study","volume":"11","author":"Moreau P.","year":"2024","journal-title":"Lancet Haematology"},{"key":"e_1_2_13_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(23)01572-0"},{"key":"e_1_2_13_83_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-0087"},{"key":"e_1_2_13_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147983"},{"key":"e_1_2_13_85_1","unstructured":"S.Kumar C. R.Bachier M.Cavo et\u00a0al. \u201cCevostamab in Patients With RRMM Who Are Triple\u2010Class Refractory and Have Received a Prior BCMA\u2010Targeted ADC or CAR T\u2010Cell: Initial Results From the Phase I\/II CAMMA 2 Study \u201dEHA 2024. (Nota: Abstract congressuale)."},{"key":"e_1_2_13_86_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0378"},{"key":"e_1_2_13_87_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153796"},{"key":"e_1_2_13_88_1","doi-asserted-by":"publisher","DOI":"10.3390\/diseases9010020"},{"key":"e_1_2_13_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899\u2010023\u201000687\u20107"},{"key":"e_1_2_13_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00043-3"},{"key":"e_1_2_13_91_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8220"},{"key":"e_1_2_13_92_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.CCR\u201015\u20100534"},{"key":"e_1_2_13_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016335"},{"key":"e_1_2_13_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30109-7"},{"key":"e_1_2_13_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102004\u201006\u20102410"},{"key":"e_1_2_13_96_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01398"},{"key":"e_1_2_13_97_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112523"},{"key":"e_1_2_13_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571\u2010018\u20100087\u20100"},{"key":"e_1_2_13_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010018\u20100036\u20104"},{"key":"e_1_2_13_100_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"e_1_2_13_101_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045\u2010023\u201001416\u2010w"},{"key":"e_1_2_13_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.024"},{"key":"e_1_2_13_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404746"},{"key":"e_1_2_13_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523\u2010011\u20100199\u20103"},{"key":"e_1_2_13_105_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011456"},{"key":"e_1_2_13_106_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.5.1658"},{"key":"e_1_2_13_107_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.115"},{"key":"e_1_2_13_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102014\u201008\u2010593251"},{"key":"e_1_2_13_109_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01533"},{"key":"e_1_2_13_110_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2010.525501"},{"key":"e_1_2_13_111_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018881003"},{"key":"e_1_2_13_112_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e31815db011"},{"key":"e_1_2_13_113_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281875"},{"key":"e_1_2_13_114_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00312"},{"issue":"3","key":"e_1_2_13_115_1","first-page":"e185","article-title":"International Myeloma Working Group (IMWG) Updated Criteria for Risk Stratification and Genomic Staging in 2025","volume":"12","author":"Sonneveld P.","year":"2025","journal-title":"Lancet Haematology"},{"key":"e_1_2_13_116_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.COT.00000000000003"},{"key":"e_1_2_13_117_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8002"},{"key":"e_1_2_13_118_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312054"},{"key":"e_1_2_13_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(22)00503\u20104"},{"key":"e_1_2_13_120_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102022\u2010157945"},{"key":"e_1_2_13_121_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102021\u2010151542"},{"key":"e_1_2_13_122_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7505"},{"key":"e_1_2_13_123_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102022\u2010140\u2010Supplement_1\u2010858"},{"key":"e_1_2_13_124_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells13100879"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.70168","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ejh.70168","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.70168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:54:12Z","timestamp":1781873652000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.70168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1111\/ejh.70168"],"URL":"https:\/\/doi.org\/10.1111\/ejh.70168","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"2025-11-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}